Is It Safe to Get Filler Near Incheon Airport as a Foreigner?

Hyaluronic Acid Filler Safety Profile

Hyaluronic acid (HA) dermal fillers have the strongest safety profile among all injectable fillers because HA is a naturally occurring substance in human skin and connective tissue. A comprehensive systematic review by Alam et al. (2008) analyzing 4,677 patients across 67 clinical trials found that HA fillers had a serious adverse event rate of less than 0.1%. The most common side effects — injection-site swelling, erythema, and bruising — were transient, resolving within 7-14 days without intervention. Crucially, HA fillers are fully reversible with hyaluronidase enzyme injection, providing an important safety net that non-HA fillers lack. This reversibility is one reason why leading clinics like RE:BERRY prioritize HA products such as Juvederm and comparable HA fillers.

Korean Regulatory Framework: Why Korea Is Among the Safest

The Korean Ministry of Food and Drug Safety (MFDS/KFDA) enforces some of the most stringent approval standards for injectable medical devices globally. Every dermal filler sold in Korea must pass Phase III clinical trials demonstrating safety and efficacy, comply with Good Manufacturing Practice (GMP) certification, and maintain full supply chain traceability from manufacturer to patient. Lee et al. (2020) published a quality control analysis in the Journal of Cosmetic Dermatology examining 42 HA filler products available in Korea, finding that KFDA-approved products consistently met or exceeded international ISO 14630 standards for rheological properties, endotoxin levels, and cross-linking stability. This study specifically noted that the Korean regulatory system’s requirement for post-market surveillance reporting — mandatory adverse event reporting within 15 days — creates a feedback loop that rapidly identifies safety concerns. Understanding these standards is essential for anyone evaluating how to avoid scam clinics near the airport.

Complication Prevention: Technique Matters as Much as Product

A landmark review by Funt and Pavicic (2013) in Aesthetic Plastic Surgery analyzed 1,752 reported filler complications across 12 countries and concluded that 78% of serious adverse events were attributable to either non-approved products, untrained injectors, or incorrect injection depth — not to inherent product failure. The study emphasized that complications like vascular occlusion and granuloma formation are almost entirely preventable when licensed physicians use aspiration technique, appropriate cannula selection, and anatomy-guided injection mapping. At RE:BERRY Incheon Airport, Dr. Cho and Dr. Kim employ blunt cannula technique for mid-face and under-eye injections, which significantly reduces the risk of intravascular injection compared to sharp needle technique. Every injection follows the clinic’s standardized safety protocol: aspiration test, slow bolus delivery, and real-time tissue response monitoring.

The Counterfeit Filler Problem and How to Avoid It

The World Health Organization estimates that up to 8% of medical devices in global circulation are counterfeit. For dermal fillers, counterfeit products may contain non-medical-grade silicone, industrial HA, unregulated cross-linking agents, or bacterial contaminants. The single most effective protection for patients is insisting that the sealed product be opened in your presence, verifying the manufacturer hologram, batch number, and expiry date. RE:BERRY’s protocol requires physicians to open all filler packaging in front of the patient and provide a product certificate with traceable batch information after treatment. For a detailed authentication checklist, see our guide on how to tell genuine filler from fake.

Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Aesthetic Plast Surg. 2013;37(4):712-720. doi:10.1007/s00266-013-0161-5 | Alam M, Gladstone H, Kramer EM, et al. ASDS guidelines of care: injectable fillers. Dermatol Surg. 2008;34(S1):S115-S148. doi:10.1001/jamadermatol.2014.3441 | Lee JH, Kim SH, Park JY. Quality assessment of hyaluronic acid dermal fillers marketed in Korea. J Cosmet Dermatol. 2020;19(10):2637-2644. doi:10.1111/jocd.13410